Key Findings:  Subjects who were informed of an increased predisposition to schizophrenia with the use of marijuana reported their likelihood and the importance of avoiding marijuana as significantly higher, especially with a past history of use.
Type of Study:  Clinical Trial
Study Sample Size:  1601
Study Result:  Positive
Research Location(s):  United States
Year of Pub:  2021
Cannabinoids Studied: 
Phytocannabinoid Source:  Not Applicable
Citation:  Lebowitz MS, et al. Experimentally exploring the potential behavioral effects of personalized genetic information about marijuana and schizophrenia risk. J Psychiatr Res. 2021; 140:316-322. doi: 10.1016/j.jpsychires.2021.05.066
Authors:  Lebowitz MS, Appelbaum PS, Dixon LB, Girgis RR, Wall MM